> top > projects > sonoma2 > docs > PubMed:32831324 > annotations
sonoma2  

PubMed:32831324 JSONTXT 21 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T0 0-24 CPA denotes Cutaneous susceptibility
T1 28-48 DISEASE denotes SARS-CoV-2 infection
T2 39-48 CPA denotes infection
T3 49-58 REG denotes according
T4 66-76 MPA denotes expression
T5 271-285 CPA denotes manifestations
T6 302-310 DISEASE denotes COVID-1
T7 303-311 DISEASE denotes COVID-19
T8 331-348 CPA denotes cutaneous tropism
T9 403-409 REG denotes infect
T10 459-473 MPA denotes susceptibility
T11 487-507 DISEASE denotes o SARS-CoV-2 infecti
T12 500-509 CPA denotes infection
T13 523-533 MPA denotes expression
T14 555-559 GENE denotes s AC
T15 557-561 GENE denotes ACE2
T16 564-571 GENE denotes d TMPRS
T17 566-573 GENE denotes TMPRSS2
T18 696-704 MPA denotes presence
T19 709-713 GENE denotes he A
T20 712-716 GENE denotes ACE2
T21 718-725 GENE denotes nd TMPR
T22 721-728 GENE denotes TMPRSS2
T23 753-763 MPA denotes expression
T24 865-878 MPA denotes co-expression
T25 878-882 GENE denotes of
T26 882-886 GENE denotes ACE2
T27 887-894 GENE denotes and TMP
T28 891-898 GENE denotes TMPRSS2
T29 1046-1050 GENE denotes of
T30 1050-1054 GENE denotes ACE2
T31 1103-1110 GENE denotes sed TMP
T32 1107-1114 GENE denotes TMPRSS2
T33 1154-1178 CPA denotes cutaneous manifestations
T34 1191-1199 DISEASE denotes with COV
T35 1196-1204 DISEASE denotes COVID-19
T36 1224-1234 REG denotes attributed
T37 1242-1247 CPA denotes virus
T38 1285-1311 CPA denotes vessels endothelial damage
T39 1328-1334 REG denotes effect
T40 1350-1372 CPA denotes inflammatory mediators
T41 1416-1421 REG denotes cause
T42 1430-1441 CPA denotes involvement
R0 T0 T2 ThemeOf Cutaneous susceptibility,infection
R1 T0 T3 ThemeOf Cutaneous susceptibility,according
R10 T12 T10 ThemeOf infection,susceptibility
R11 T13 T10 ThemeOf expression,susceptibility
R12 T12 T13 ThemeOf infection,expression
R13 T15 T10 ThemeOf ACE2,susceptibility
R14 T15 T12 ThemeOf ACE2,infection
R15 T15 T13 ThemeOf ACE2,expression
R16 T17 T10 ThemeOf TMPRSS2,susceptibility
R17 T17 T12 ThemeOf TMPRSS2,infection
R18 T17 T13 ThemeOf TMPRSS2,expression
R19 T20 T18 ThemeOf ACE2,presence
R2 T2 T3 ThemeOf infection,according
R20 T20 T23 ThemeOf ACE2,expression
R21 T22 T18 ThemeOf TMPRSS2,presence
R22 T22 T23 ThemeOf TMPRSS2,expression
R23 T26 T24 ThemeOf ACE2,co-expression
R24 T28 T24 ThemeOf TMPRSS2,co-expression
R25 T33 T36 ThemeOf cutaneous manifestations,attributed
R26 T35 T33 ThemeOf COVID-19,cutaneous manifestations
R27 T35 T36 ThemeOf COVID-19,attributed
R28 T37 T36 ThemeOf virus,attributed
R29 T39 T42 CauseOf effect,involvement
R3 T2 T4 ThemeOf infection,expression
R30 T40 T39 ThemeOf inflammatory mediators,effect
R31 T40 T41 ThemeOf inflammatory mediators,cause
R32 T40 T42 CauseOf inflammatory mediators,involvement
R33 T42 T41 ThemeOf involvement,cause
R4 T4 T3 ThemeOf expression,according
R5 T7 T5 ThemeOf COVID-19,manifestations
R6 T7 T8 ThemeOf COVID-19,cutaneous tropism
R7 T7 T9 ThemeOf COVID-19,infect
R8 T8 T5 ThemeOf cutaneous tropism,manifestations
R9 T8 T9 ThemeOf cutaneous tropism,infect